Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.

Summary

To learn if asciminib can help to control CML. The safety and effects of this drug will also be studied.

Timeline

Start

2024-01-31

Primary completion

2033-07-01

Completion

2035-07-01

Drugs

Indications